BLENREP Trademark

Trademark Overview

On Tuesday, November 11, 2014, a trademark application was filed for BLENREP with the United States Patent and Trademark Office. The USPTO has given the BLENREP trademark a serial number of 86451001. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 23, 2024. This trademark is owned by Glaxo Group Limited. The BLENREP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
blenrep

General Information

Serial Number86451001
Word MarkBLENREP
Filing DateTuesday, November 11, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 23, 2024
Registration Number5258533
Registration DateTuesday, August 8, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, February 23, 2024CANCELLED SEC. 8 (6-YR)
Thursday, June 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 8, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, August 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 8, 2017REGISTERED-PRINCIPAL REGISTER
Monday, July 3, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, June 9, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, June 9, 2017TEAS DELETE 1(B) BASIS RECEIVED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2016SOU EXTENSION 3 GRANTED
Thursday, December 1, 2016SOU EXTENSION 3 FILED
Thursday, December 1, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 3, 2016SOU EXTENSION 2 GRANTED
Tuesday, May 31, 2016SOU EXTENSION 2 FILED
Friday, July 1, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2016SOU TEAS EXTENSION RECEIVED
Friday, November 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 18, 2015SOU EXTENSION 1 GRANTED
Wednesday, November 18, 2015SOU EXTENSION 1 FILED
Wednesday, November 18, 2015SOU TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 14, 2014NEW APPLICATION ENTERED

Related Keywords

blenrep pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological